Risk factors
SkyAI (SKYA) risk factors
Item 1A of every SkyAI, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors46 risks29 new10 dropped6 reworded
SkyAI shifted its business strategy to include a digital asset treasury focused on Solana (SOL). Net losses surged to $282.5 million in 2025 alongside 2,000,000 SOL holdings.
Filed Mar 31, 2026 - FY2024 10-K risk factors27 risks
SkyAI is an early-stage medical device company facing multi-million dollar losses and zero revenue to date. The business depends entirely on successfully commercializing Securgard, Sologard, and Sharps Provensa safety syringes. Strict healthcare regulations, intellectual property protection, and substantial capital raising needs dominate the risk profile.
Filed Mar 27, 2025